America-based vaccine company Moderna has claimed that its coronavirus vaccine is found to be 96% effective in adolescents between the ages of 12 to 17.
The vaccine developer said on Tuesday that no further side-effects were seen in the teens which were different from what had been seen in adults.
If approved, Moderna will join Pfizer to get authorization for school-aged children.
Moderna has said it will be submitting the findings of the clinical trials to the United States Food and Drug Administration. The approval from FDA will mean the vaccine will be second to get approved for the adolescents.
Moderna is currently proven effective for children above 18 and is being used for that aged group.
If it follows the trend of Pfizer's vaccine, the vaccine will likely get emergency approval for usage in teens in early July.
/Next-COVID-Strain.jpeg "People walk past an advertisement warning about COVID-19 in Manchester, England, on Saturday. (Photo: Reuters)")
/COVID-Global-Emergency-WHO.webp "Millions of cases are being reported each week, but surveillance has declined, making it difficult to get a full overview of the situation and how the virus is mutating. (Photo: Reuters)")
/WHO-COVID-END.jpg "Tedros Adhanom Ghebreyesus, Director General of WHO, speaks with Charles Michel, EU Council President, during the G7 leaders summit at Castle Elmau in Kruen, Germany, on Monday, June 27, 2022. (Michael Kappeler/Pool via AP)")
/Monkeypox-Outbreak-Health-Emergency.jpg "Daniel Rofin, 41, receives a vaccine against Monkeypox from a health professional in medical center in Barcelona. (Photo: AP)")
/South-American-Monkeypox-Cases.webp "The monkeypox virus has been found in 78 countries since early May according to the WHO [File: Rick Bowmer/AP Photo]")
/Global-Health-Emergency-Monkeypox.jpg "Test tubes labelled \"Monkeypox virus positive\" are seen in this illustration taken May 22, 2022. (Photo: Reuters/Dado Ruvic)")
